G

Georges Imbert

Novartis (Switzerland)

Publishes on Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Alzheimer's disease research and treatments. 24 papers and 3.5k citations.

24Publications

3.5kTotal Citations

Genetic Neurodegenerative Diseases Mitochondrial Function and Pathology Alzheimer's disease research and treatments Neurological disorders and treatments Monoclonal and Polyclonal Antibodies Research

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats

Georges Imbert, Frédéric Saudou, Gaël Yvert et al.|Nature Genetics|1996

Cited by 853

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion

Gilles David, Nacer Abbas, Giovanni Stévanin et al.|Nature Genetics|1997

Cited by 771

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

Yvon Trottier, Yves Lutz, Giovanni Stévanin et al.|Nature|1995

Cited by 654

Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form

Yvon Trottier, Didier Devys, Georges Imbert et al.|Nature Genetics|1995

Cited by 447

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Bengt Winblad, Niels Andreasen, Lennart Minthon et al.|The Lancet Neurology|2012

Cited by 302